Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Fourth Oaktree Letter

6 Jun 2018 16:49

RNS Number : 5575Q
Ranger Direct Lending Fund PLC
06 June 2018
 

Ranger Direct Lending Fund plc

("Ranger" or the "Company")

 

Response to Fourth Oaktree Letter

 

The independent directors of Ranger ("Independent Directors") note the announcement from Oaktree Capital Management, L.P. ("Oaktree") today.

 

The Independent Directors welcome that Oaktree now acknowledges that a winding up of Ranger is not the only option for the future of the Company and responds to Oaktree's other comments below.

 

Review Process

The investment management review process ("the process") has been run by the Independent Directors who note that Oaktree is the only major shareholder in Ranger not to take up the opportunity of a presentation from Ares Management LLC ("Ares") on the detail of its proposed future investment strategy. The Independent Directors believe that the new investment policy will enhance the capital stability of the Company going forward to the benefit of both ordinary shareholders and Zero Dividend Preference ("ZDP") shareholders.

 

During the process, the Independent Directors have looked to balance the interests of all stakeholders. The process involved two rounds of written submissions from potential investment managers, including details dealing with the legitimate interests of the ZDP shareholders. Oaktree was invited to participate in the process but declined. It is the Independent Director's view that if Oaktree had fully engaged in the process, it would understand how the Independent Board conducted a robust, fair and balanced process.

 

The Independent Directors and their advisers continue to be in positive discussions with shareholders on the Ares proposal and related matters. Ares is also in dialogue with shareholders on the detail of the proposed new investment policy. The Independent Directors believe that the majority of shareholders want this level of engagement to be able to reach an informed view on the future of the Company.

 

Future of the Company

The Independent Directors welcome Oaktree's statement today that its nominees for Board positions "are committed to exploring all strategic alternatives for the Company in order to maximise value", and that they are willing to engage "with potential new managers including Ares". However, the Independent Directors have to reflect that this public pronouncement is not corroborated by Oaktree's recent conduct. In its open letter to shareholders of 4 May 2018, Oaktree concluded that a winding up of Ranger was the only way forward for the Company. Oaktree has since engaged in a disruptive campaign seeking to force through a winding up of the Company, irrespective of the interests of other longer-term shareholders.

 

Future Board Composition

The Independent Directors of Ranger have engaged actively with shareholders during the process on the future composition of the Board. The EGM circular will include a commitment to appoint additional non-executive directors with relevant experience, after further consultation with shareholders. If appointed, Ares will not have a Board representative, and non-independent non-executive director, Mr. K. Scott Canon, the CEO of Ranger Capital Group, has confirmed he will resign as a director of the Company following the EGM. The Independent Directors welcome the recommendation by Institutional Shareholder Services (ISS), that clients vote against resolutions 8,9.10,11 and 12 at the AGM to be held on 19 June 2018.

 

Recommendation

The Board will publish all relevant information ahead of shareholders making a decision on the AGM resolutions relating to the appointment and removal of directors. As stated in the notice of the meeting, the Board recommends that shareholders vote against resolutions 8, 9, 10, 11 and 12 at the AGM to be held on 19 June 2018.

 

An EGM circular will be sent to shareholders following regulatory approval.

 

Contacts:

 

Ranger Direct Lending Fund plc

Christopher Waldron (Chairman)

 

Via Kinmont

Kinmont

Gavin Kelly

 

Tel: +44 (0)20 7087 9134

 

Liberum

Joshua Hughes

 

Tel: +44 (0)20 3100 2000

Redleaf (for media enquiries)

Robin Tozer

Tel: + 44 (0) 20 3757 6867

ranger@redleafpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBUGDLLSGBGIL
Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.